Deferasirox for managing iron overload in people with thalassaemia-Reference-Cited by-同舟云学术

Deferasirox for managing iron overload in people with thalassaemia

Published:2012-02-15 Issue: Volume: Page:
ISSN:
Container-title:Cochrane Database of Systematic Reviews
language:
Short-container-title:

Author:

Meerpohl Joerg J,Antes Gerd,Rücker Gerta,Fleeman Nigel,Motschall Edith,Niemeyer Charlotte M,Bassler Dirk

Publisher

John Wiley & Sons, Ltd

Reference115 articles.

1. Iron chelation therapy with deferasirox (Exjade (R), ICL670) or deferoxamine is effective in reducing iron overload in patients with advanced fibrosis and cirrhosis;Angelucci;Blood,2005

2. Iron chelation therapy with deferasirox (Exjade®, ICL670) or deferoxamine results in reduced hepatocellular inflammation and improved liver function in patients with transfusion-dependent anemia [abstract];Brissot;Blood,2005

3. Phase III evaluation of once-daily, oral therapy with ICL670 (Exjade (R)) versus deferoxamine in patients with beta-thalassemia and transfusional hemosiderosis;Cappellini;Blood,2004

4. Patient satisfaction with deferasirox (Exjade®, ICL670) an oral form of chelation therapy versus deferoxamine an infused chelation therapy [abstract];Cappellini;Blood,2005

5. Prospective evaluation of patient-reported outcomes during treatment with deferasirox or deferoxamine for iron overload in patients with beta-thalassemia;Cappellini;Clinical Therapeutics,2007

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging regulatory mechanisms in cardiovascular disease: Ferroptosis;Biomedicine & Pharmacotherapy;2024-05

2. The effects of curcumin on hepatic T2*MRI and liver enzymes in patients with β‐thalassemia major: a double‐blind randomized controlled clinical trial;Frontiers in Pharmacology;2023-12-18

3. Therapeutic Approaches Targeting Ferroptosis in Cardiomyopathy;Cardiovascular Drugs and Therapy;2023-11-06

4. Iron accumulation and lipid peroxidation: implication of ferroptosis in diabetic cardiomyopathy;Diabetology & Metabolic Syndrome;2023-07-19

5. Comparison of red blood corpuscle indices versus hemoglobin high-performance liquid chromatography as a screen for hemoglobinopathies in pregnant women;Journal of Marine Medical Society;2023